Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
This is an excerpt from todays Press Release

SHAWNEE MISSION, Kan., April 23 /PRNewswire-FirstCall/ -- Bayer said it is pleased at the results of two independent scientific studies that show banning the use of Baytril® 3.23% enrofloxacin for the treatment of air sacculitis, a pneumonia-like infection in poultry, could potentially compromise food safety and have a significant negative impact on human health.

"These studies strongly support the continued therapeutic use of Baytril for poultry and clearly identify the human health benefit, a factor that has not yet been fully considered by FDA," said John B. Payne, president and general manager, Bayer HealthCare LLC, Animal Health Division.

http://biz.yahoo.com/prnews/030423/phw026_1.html
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement